SCHEMBL115507

SCHEMBL115507

CCNc1ncc(-c2ccccc2N2CCN(C(C=O)n3nc(C)cc3C)CC2)cn1

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CXCR3 P49682 1/20 0.40
KCNH2 Q12809 1/20 0.40
BRD4 O60885 1/20 0.34
TNK2 Q07912 3/20 0.33
JAK2 O60674 2/20 0.32
ALDH1A1 P00352 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2D6 P10635 1/20 0.31
HPGD P15428 1/20 0.31
CASP1 P29466 1/20 0.31
CASP7 P55210 1/20 0.31
HIF1A Q16665 1/20 0.31
HSD17B10 Q99714 1/20 0.31
MAPT P10636 1/20 0.31
ALOX15 P16050 1/20 0.30
DHFR P00374 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL113252 0.91 CXCR3 (0.41) CXCR3KCNH2TNK2JAK2MAPT
SCHEMBL115477 0.88 CXCR3 (0.42) CXCR3KCNH2MAPTDHFR
SCHEMBL114545 0.87 CXCR3 (0.40) CXCR3KCNH2TNK2
SCHEMBL114135 0.86 CXCR3 (0.41) CXCR3KCNH2TNK2ALDH1A1HSD17B10
SCHEMBL115833 0.86 CXCR3 (0.41) CXCR3KCNH2DHFR
SCHEMBL113125 0.84 CXCR3 (0.40) CXCR3KCNH2ALDH1A1CASP1MAPT
SCHEMBL114268 0.84 CXCR3 (0.40) CXCR3KCNH2JAK2HPGDHSD17B10
SCHEMBL113545 0.84 CXCR3 (0.42) CXCR3KCNH2MAPTDHFR
SCHEMBL113986 0.84 CXCR3 (0.40) CXCR3KCNH2ALDH1A1MAPTDHFR
SCHEMBL114041 0.84 CXCR3 (0.39) CXCR3KCNH2ALDH1A1CASP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2424840-A1 CXCR3 RECEPTOR ANTAGONISTS Boehringer Ingelheim International GmbH (DE) 2012-03-07 EP disclosed
WO-2010126811-A1 CXCR3 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-11-04 WO disclosed